Predictors of omega-3 index in patients with acute myocardial infarction

Mayo Clinic Proceedings

Volumn 86, Issue 7, 2011, Pages 626-632

  Salisbury, Adam C ^a   Amin, Amit P ^a   Harris, William S ^b   Chan, Paul S ^a   Gosch, Kensey L ^a   Rich, Michael W ^c   O'Keefe Jr , James H ^a   Spertus, John A ^a  

^a Saint Luke's Mid America Heart and Vascular Institute   (United States)

^b UNIVERSITY OF SOUTH DAKOTA   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OMEGA 3 FATTY ACID;

ACUTE HEART INFARCTION; ADULT; AGE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIET SUPPLEMENTATION; EATING HABIT; ERYTHROCYTE; FAST FOOD; FEMALE; FISH; FOOD INTAKE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PROSPECTIVE STUDY; RACE; RISK FACTOR; SMOKING;

EID: 79959692919     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/mcp.2011.0005     Document Type: Article

References (15)

1. Harris WS, Poston WC, Haddock CK. Tissue n-3 and n-6 fatty acids and risk for coronary heart disease events. Atherosclerosis. 2007;193(1):1-10. (Pubitemid 46776717)
2. Pottala JV, Garg S, Cohen BE, Whooley MA, Harris WS. Blood eicosapentaenoic and docosahexaenoic acids predict all-cause mortality in patients with stable coronary heart disease: the Heart and Soul study. Circ Cardiovasc Qual Outcomes. 2010;3(4):406-412.
3. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet. 1999;354(9177):447-455.
4. Wang C, Harris WS, Chung M, et al. n-3 Fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review. Am J Clin Nutr. 2006;84(1):5-17. (Pubitemid 44699166)
5. Tavazzi L, Maggioni AP, Marchioli R, et al. Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSIHF trial): a randomised, double-blind, placebo-controlled trial. Lancet. 2008;372(9645):1223- 1230.
6. Sands SA, Reid KJ, Windsor SL, Harris WS. The impact of age, body mass index, and fish intake on the EPA and DHA content of human erythrocytes. Lipids. 2005;40(4):343-347.
7. Block RC, Harris WS, Pottala JV. Determinants of blood cell omega-3 fatty acid content. Open Biomark J. 2008;1:11-16.
8. Harris WS, Von Schacky C. The Omega-3 Index: a new risk factor for death from coronary heart disease? Prev Med. 2004;39(1):212-220.
9. Block RC, Harris WS, Reid KJ, Sands SA, Spertus JA. EPA and DHA in blood cell membranes from acute coronary syndrome patients and controls. Atherosclerosis. 2008;197(2):821-828. (Pubitemid 351417881)
10. Zou G. A modified Poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004;159(7):702-706. (Pubitemid 38405384)
11. Hosmer DW, Lemeshow S. Applied Logistic Regression. New York, NY: John Wiley and Sons, Inc; 2000.
12. Kris-Etherton PM, Harris WS, Appel LJ. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation. 2002;106(21):2747-2757. (Pubitemid 35364932)
13. Kromhout D, Giltay EJ, Geleijnse JM. n-3 fatty acids and cardiovascular events after myocardial infarction. N Engl J Med. 2010;363(21):2015-2026.
14. Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Energy, Carbohydrates, Fiber, Fat, Protein and Amino Acids (Macronutrients). Washington, DC: National Academies Press; 2005.
15. Rauch B, Schiele R, Schneider S, et al. OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction. Circulation. 2010;122(21):2152-2159.